melanoma

Impact of COVID-19 on melanoma treatment 3:02
Impact of COVID-19 on melanoma treatment
Bettina Ryll
Access to novel therapies in melanoma 3:25
Access to novel therapies in melanoma
Bettina Ryll
Melanoma Patient Network Europe 2:12
Melanoma Patient Network Europe
Bettina Ryll
New models for patient care: advanced pharmacy practitioners 2:31
New models for patient care: advanced pharmacy practitioners
Dharmisha Chauhan
Treatment options for mucosal melanoma patients 1:21
Treatment options for mucosal melanoma patients
Marcus Butler
KEYNOTE-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma 3:35
KEYNOTE-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
Georgina Long
Preventing melanoma through public health education 1:36
Preventing melanoma through public health education
Georgina Long
Oncolytic virus therapy in the treatment of melanoma 3:01
Oncolytic virus therapy in the treatment of melanoma
Kevin Harrington
Role of BRAF mutation in the treatment for melanoma 2:58
Role of BRAF mutation in the treatment for melanoma
Dirk Schadendorf
Immunotherapy and targeted therapies for melanoma 5:40
Immunotherapy and targeted therapies for melanoma
Caroline Robert
Current clinical perspectives on targeted therapy and immunotherapy for melanoma 2:12
Current clinical perspectives on targeted therapy and immunotherapy for melanoma
Caroline Robert
Clinical developments in the treatment for melanoma 5:00
Clinical developments in the treatment for melanoma
Axel Hauschild
Aggressive care at the end-of-life for younger cancer patients: ASCO’s Choosing Wisely campaign 4:25
Aggressive care at the end-of-life for younger cancer patients: ASCO’s Choosing Wisely campaign
Ronald Chen
Global differences in cancer drug prices: a comparative analysis 4:28
Global differences in cancer drug prices: a comparative analysis
Daniel Goldstein
Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway 6:11
Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway
John Hainsworth
CheckMate 172 trial of nivolumab for advanced melanoma: preliminary results 2:01
CheckMate 172 trial of nivolumab for advanced melanoma: preliminary results
Paolo Ascierto
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals